Allergy Research Group announces its next webinar with Dr. Carrie Decker on Fatty Liver Disease – Why it Matters to You, and Things You Can Do About It. The live webinar will take place on Wednesday, August 14th at 3 pm PDT.

In this webinar, learn more about non-alcoholic fatty liver disease (NAFLD), a condition that often accompanies obesity and type 2 diabetes, and, more importantly, the evidence behind nutritional supplements that help improve it (as well as diabetes).

We hope you can join us live on August 14th at 3 pm PDT. If not, don’t worry, signing up will still grant you access to the webinar recording.

The webinar will last 40 minutes, including a 10-minute Q & A session.

A special discount offer on Allergy Research Group products will be revealed to live attendees before the webinar ends.

Register for the free webinar today: https://zoom.us/webinar/register/WN_CgHyhHZ0QyqmCWZVDM1bCA

A link to a recording of the webinar will be emailed to all registrants.

Dr. Carrie Decker graduated with honors from the National College of Natural Medicine (now the National University of Natural Medicine) in Portland, Oregon. Dr. Decker sees patients at her office in Portland, OR, as well as remotely, with a focus on gastrointestinal disease, mood imbalances, eating disorders, autoimmune disease, and chronic fatigue. Prior to becoming a naturopathic physician, Dr. Decker was an engineer, and obtained graduate degrees in biomedical and mechanical engineering from the University of Wisconsin-Madison and the University of Illinois at Urbana-Champaign, respectively. Dr. Decker supports Allergy Research Group as the Executive Editor for the quarterly Focus Newsletter, is the author of additional educational materials, and supports the product development team. Dr. Decker continues to enjoy academic research and writing, and uses these skills to support integrative medicine education as a writer and contributor to various resources.

Contact:
Allergy Research Group Marketing Department
marketing@allergyresearchgroup.com

Allergy Research Group regrets to announce the departure of Wolfgang Kuchen as the president of the company.  We appreciate his significant contribution to the company’s growth during the past three years and sincerely wish him nothing but success for his future endeavors. Wolfgang’s last day with the company was June 30. 2019.

The Board of Directors has appointed Rory Mahony as the new President of Allergy Research Group effective immediately.  Rory brings more than 40 years of experience in the dietary supplement industry, both domestic and international.

He has served in upper management positions as well as COO and General Manager for Nature’s Way including Senior VP at Integrative Therapeutics.

The Allergy Research Group team is working diligently to make this transition as smooth as possible and continue to operate as usual.

Please join us in welcoming Rory to Allergy Research Group.

Contact Information:
Rory Mahony, President
Allergy Research Group
rory.mahony@allergyresearchgroup.com
1-385-466-2128 Cell

Allergy Research Group announces it upcoming webinar: Molecular Hydrogen: Preeminent Antioxidant of the 21st Century. The live webinar will take place on Wednesday, July 17^th at 3:00 p.m. PST.

Join us with Tyler LeBaron, molecular hydrogen researcher and expert, to learn what molecular hydrogen is, how to get it, and the mechanisms via which it acts in the body. Tyler will discuss the clinical significance of molecular hydrogen, reviewing scientific literature of the effects hydrogen has on oxidation, inflammation, and health optimization.

The webinar will last 40 minutes, including a 10-minute Q & A session. A special discount offer on Allergy Research Group products will be revealed to live attendees before the webinar ends.

We hope you can join us live on July 17th at 3:00 pm PST. If not, don’t worry, signing up will still grant you access to the webinar recording.

Register for the free webinar today: https://zoom.us/webinar/register/WN_R5D0jhaWQC2hgP6c1ll0KA

A link to a recording of the webinar will be emailed to all registrants.

About Tyler W. LeBaron: Tyler W. LeBaron is the Founder and Executive Director of the science-based nonprofit Molecular Hydrogen Institute. With a bachelor’s degree in biochemistry and master’s degree in exercise physiology, Tyler went on to serve as an adjunct instructor of physiology at Brigham Young University and intern at Nagoya University in the department of Neurogenetics, researching the molecular mechanisms of hydrogen gas on cell signaling pathways. He is a director of the International Hydrogen Standards Association (IHSA) and the International Molecular Hydrogen Association (IMHA). He is the author or coauthor of numerous publications on the topic of molecular hydrogen and speaks regularly at medical conferences in the U.S. and academic biomedical hydrogen symposia and conferences around the world. He is also a member of the Academic Committee of Taishan Institute for Hydrogen Biomedical Research. He collaborates with researchers at home and abroad, and helps advance the education, research, and awareness of hydrogen as a therapeutic medical gas.

Contact:
Allergy Research Group Marketing Department marketing@allergyresearchgroup.com

Allergy Research Group announces its upcoming webinar on Cognitive Optimization: Combining Nootropics, Nitric Oxide, and Antioxidants for Peak Performance. The live webinar will take place on Wednesday, June 19th at 3:00 p.m. PST.

Join us with Dr. Todd A. Born, ND, CNS to learn about nutritional tools that not only support optimal cognitive health now but also protect against neurodegenerative changes.

The webinar will last 30 minutes, including a 10-minute Q & A session. A special discount offer on Allergy Research Group products will be revealed to live attendees before the webinar ends.

We hope you can join us live on June 19th at 3:00 pm PST. If not, don’t worry, signing up will still grant you access to the webinar recording.

Register for the free webinar today: https://zoom.us/webinar/register/WN_pPnIQFX-QqeFxqUegKStKA

A link to a recording of the webinar will be emailed to all registrants.

Contact:
Allergy Research Group Marketing Department
marketing@allergyresearchgroup.com

Allergy Research Group announces its upcoming webinar on Endocannabinoids, Essential Fatty Acids, and Bioregulation. The live webinar will take place on Wednesday, May 22nd at 3:00 PM PST.

Join us with Evan DeMarco to learn more about how the endocannabinoid system and essential fatty acids work together in the body to regulate neuroinflammation, mood, and the stress response. Additionally, the role that emerging technology plays in new product development as well as the current legal landscape of the non-psychoactive compounds found in hemp will be discussed.

The endocannabinoid system (ECS) is comprised of cannabinoid receptors, endogenous lipid-based ligands (binding molecules) for those receptors, and enzymes that synthesize, degrade, and regulate the ligands. The ECS regulates homeostasis through a wide variety of molecular and biochemical mechanisms, including intercellular signaling to blunt excessive responses. The ECS has been demonstrated as pivotal in the regulation of perceived sleep, mental stress, neuroendocrine status, emotional control, and pain sensation. Phytobioactive compounds derived from agricultural hemp may play important roles in regulating the ECS. Similarly, omega-3 status also impacts cellular function and inflammation, and supplementation with EPA and DHA in combination with phytobioactive compounds derived from hemp may provide synergistic benefits in the optimization of the ECS.

Evan DeMarco is a sports medicine and nutrition expert, published author, public speaker, and frequent guest on television, radio, and digital platforms. He is a successful entrepreneur whose interest in diet, health, and supplements began as an athlete and consumer determined to improve an industry that was going through massive transformation. Currently, Evan serves as the Director of Market Development at The KD Pharma Group.

A special discount offer on Allergy Research Group products will be revealed to live attendees before the webinar ends.

We hope you can join us live on May 22nd at 3:00 pm PST. If not, don’t worry, signing up will still grant you access to the webinar recording.

Register for the free webinar today: https://zoom.us/webinar/register/WN_gdXvxTCCTiOvJBeMPo7eJw

A link to a recording of the webinar will be emailed to all registrants.

Contact:
Allergy Research Group Marketing Department
marketing@allergyresearchgroup.com

Allergy Research Group announces its upcoming webinar on Cardiovascular and Metabolic Health, Naturally. The live webinar will take place on Wednesday, April 17^th at 3:00 p.m. PST.

As we celebrate turning 40 at Allergy Research Group, we continue to look at natural strategies to help you combat aging. In this webinar, Dr. Carrie Decker, ND discusses innovative approaches for supporting cardiovascular and metabolic health.

The webinar will last 30 minutes, including a 10-minute Q & A session. A special discount offer on Allergy Research Group products will be revealed to live attendees before the webinar ends.

We hope you can join us live on April 17th at 3:00 pm PST. If not, don’t worry, signing up will still grant you access to the webinar recording.

Register for the free webinar today: https://zoom.us/webinar/register/WN_2irqLLNqSDyvtnEPNsgs3Q

A link to a recording of the webinar will be emailed to all registrants.

Contact:
Allergy Research Group Marketing Department
marketing@allergyresearchgroup.com

Allergy Research Group announces Cold, Flu, & Allergy Support: Natural Therapies Beyond the Basics webinar to take place on March 13th at 3:00 p.m. PST.

Join Dr. Erica Zelfand for an information-packed webinar on targeted therapies for immune support. Going beyond the basics, Dr. Zelfand will introduce novel nutrients, herbs, and natural constituents to help you and your patients get through the dregs of cold and flu season and thrive through allergy season. Understand the mechanisms behind common prescriptions, and learn the nuances of some lesser known but powerful therapies as well.

The webinar will last 30 minutes, including a 10-minute Q & A session. A special discount offer on Allergy Research Group products will be revealed to live attendees before the webinar ends.

We hope you can join us live on March 13th at 3:00 p.m. PST. If not, don’t worry, signing up will still grant you access to the webinar recording.

Register for the free webinar today: https://zoom.us/webinar/register/WN_2Ij0sA56RCquVjhYdFPHYA

A link to a recording of the webinar will be emailed to all registrants.

About Dr. Erica Zelfand:
Dr. Erica Zelfand is a family physician, medical writer, and teacher, with special interests in hormones, autoimmunity, and the mind/body connection. She is deeply committed to a patient-centered, root-cause-oriented, nature-honoring approach to healing. After graduating from medical school with high honors, Dr. Zelfand completed a family practice residency at the National University of Natural Medicine, followed by an additional four years of post-doctoral training in pediatrics. As an engaging presenter, Dr. Zelfand enjoys being adjunct faculty at her alma mater and appearing on numerous podcasts and health summits.

Contact:
Allergy Research Group Marketing Department
marketing@allergyresearchgroup.com

Allergy Research Group announces Tocotrienols as Agents for Cardiovascular, Liver, and Metabolic Health webinar to take place on February 13th at 3:00 p.m. PST.

Join Dr. Barrie Tan, founder of American River Nutrition, for a discussion of new data showing how tocotrienols, a form of vitamin E, support cardiovascular, liver, and metabolic health.

The webinar will last 30 minutes, including a 10-minute Q & A session. A special discount offer on Allergy Research Group products will be revealed to live attendees before the webinar ends.

We hope you can join us live on Wednesday, February 13th at 3:00 pm PST. If not, signing up will still grant you access to the webinar recording.

Register for the free webinar today: https://zoom.us/webinar/register/WN_8V9P68rJSdi_AMf7RLoQhg

A link to a recording of the webinar will be emailed to all registrants.

About Dr. Barrie Tan:
Dr. Barrie Tan earned his doctorate in chemistry (University of Otago, New Zealand; 1979), and became a professor of chemistry and food science/nutrition (University of Massachusetts, Amherst; 1982-1992). His research expertise includes lipid-soluble nutrients (carotenoids, E vitamers, CoQ10, and omega-3s). He was the first to introduce tocotrienol’s benefits to the nutrition industry, and developed the first-ever tocopherol-free tocotrienol product derived from annatto. Today, his research focuses on lipid-soluble nutrients that impact chronic conditions. Dr. Tan is the senior editor of Tocotrienols: Vitamin E Beyond Tocopherols (2013), and continues to collaborate with numerous universities worldwide to further tocotrienol research.

Contact:
Allergy Research Group Marketing Department
marketing@allergyresearchgroup.com

Allergy Research Group announces its next webinar: Detoxification: More Than Just a 10-Day Cleanse to take place on January 16th at 3:00 p.m. PST.

Dr. Born will thoroughly discuss rationales for optimizing detoxification in our modern world, go over basic biochemical pathways and physiology of hepatic detoxification, as well as safe and effective methods, along with nutrients and botanicals to enhance detoxification.

The webinar will last 30 minutes, including a 5-minute Q & A session. A special discount offer on Allergy Research Group products will be revealed to live attendees before the webinar ends.

We hope you can join us live on Wednesday, January 16th at 3:00 pm PST. If not, signing up will still grant you access to the webinar recording.

Register: https://zoom.us/webinar/register/WN_b4RAJtFIQ2-SvWHlmKRv5g

A link to a recording of the webinar will be emailed to all registrants.

Contact:
Allergy Research Group Marketing Department
marketing@allergyresearchgroup.com

Alameda, CA – FOR IMMEDIATE RELEASE: Allergy Research Group continues its heritage of bringing innovative nutritional supplements to the professional market by expanding our new, premium quality Essential-Biotic™ line of probiotics. All of the products in the Essential-Biotic™ line are shelf-stable, gluten-free, and non-dairy.

Essential-Biotic™ HEART with LRC™ and CoQ10 contains the clinically studied strain Lactobacillus reuteri NCIMB 30242 (LRC™) and CoQ10 in delayed-release capsules (DRcaps™ ).* In addition to gastrointestinal benefits, this probiotic strain along with CoQ10 provides synergistic support for the cardiovascular system, and helps support a normal, healthy lipid balance in the blood.*

• Lactobacillus reuteri LRCâ„¢ is shown to support normal, healthy cholesterol and vitamin D levels in the blood, and promotes overall digestive system health*
• Coenzyme Q10 is shown to enhance production of cellular energy (ATP) and support the function of the cardiovascular system*
• DRcapsâ„¢ are clinically shown to protect probiotics from harmful gastric acids*

Coming Soon! Essential-Biotic™ SYNBIOTIC with DDS® -1, UABla-12™ and XOS is a synergistic blend of two clinically tested strains of probiotics along with PreticX™  xylooligosaccharides (XOS).* Health benefits of XOS typically have been observed at one to five grams per day, a lower dose than required for other prebiotics such as fructooligosaccharides (FOS).*

To learn more about these products, visit www.allergyresearchgroup.com, or call our customer service team at 1-800-545-9960, extension 2.

CONTACT:
Dan Mallar, National Sales Director
dan.mallar@allergyresearchgroup.com

DDS®, UABla-12™, and LRC™ are trademarks of UAS Laboratories, LLC and used under license.

PreticX â„¢ is covered by registered and pending U.S. Patents. PreticXâ„¢ is a trademark of AIDP, Inc. PreticXâ„¢ is distributed exclusively by AIDP, Inc.

With DRcaps â„¢ Delayed Release capsules. DRCAPS and DRCAPS and Design are trademarks used under license.

*This statement has not been evaluated by the U.S. Food and Drug administration. The product is not intended to diagnose, treat, cure, or prevent any disease.